Alecta Pensionsforsakring Omsesidigt Has Lowered Its Varian Medical Systems (VAR) Stake, 6 Analysts Covering GasLog Ltd (GLOG)

June 12, 2017 - By Stephen Andrade

Alecta Pensionsforsakring Omsesidigt decreased Varian Medical Systems (VAR) stake by 11.89% reported in 2016Q4 SEC filing. Alecta Pensionsforsakring Omsesidigt sold 400,000 shares as Varian Medical Systems (VAR)’s stock rose 13.68%. The Alecta Pensionsforsakring Omsesidigt holds 2.96 million shares with $266.11 million value, down from 3.36 million last quarter. Varian Medical Systems now has $9.31 billion valuation. The stock decreased 0.92% or $0.95 on June 9, reaching $102.27. About shares traded. Varian Medical Systems, Inc. (NYSE:VAR) has risen 29.46% since June 12, 2016 and is uptrending. It has outperformed by 12.76% the S&P500.

Among 9 analysts covering GasLog (NYSE:GLOG), 6 have Buy rating, 0 Sell and 3 Hold. Therefore 67% are positive. GasLog had 20 analyst reports since August 7, 2015 according to SRatingsIntel. The stock has “Neutral” rating by Citigroup on Monday, February 22. The firm has “Market Perform” rating given on Thursday, December 17 by Wells Fargo. JP Morgan upgraded GasLog Ltd (NYSE:GLOG) on Tuesday, February 21 to “Neutral” rating. Citigroup maintained GasLog Ltd (NYSE:GLOG) on Friday, August 7 with “Buy” rating. Danske Bank initiated it with “Hold” rating and $15 target in Tuesday, August 18 report. The stock of GasLog Ltd (NYSE:GLOG) has “Buy” rating given on Tuesday, February 21 by Seaport Global Securities. Wells Fargo upgraded GasLog Ltd (NYSE:GLOG) on Wednesday, January 25 to “Outperform” rating. The firm has “Buy” rating by ABN Amro given on Friday, September 4. The stock of GasLog Ltd (NYSE:GLOG) has “Underweight” rating given on Wednesday, March 16 by JP Morgan. As per Wednesday, November 23, the company rating was initiated by Seaport Global Securities. See GasLog Ltd (NYSE:GLOG) latest ratings:

26/04/2017 Broker: Credit Suisse Rating: New Target: $21.00 Initiate
21/02/2017 Broker: JP Morgan Old Rating: Underweight New Rating: Neutral Upgrade
21/02/2017 Broker: Seaport Global Securities Old Rating: Neutral New Rating: Buy Old Target: $18 New Target: $23 Upgrade
15/02/2017 Broker: Citigroup Old Rating: Neutral New Rating: Buy Upgrade
25/01/2017 Broker: Wells Fargo Old Rating: Market Perform New Rating: Outperform Upgrade

Analysts await Varian Medical Systems, Inc. (NYSE:VAR) to report earnings on July, 26. They expect $0.94 earnings per share, down 22.95% or $0.28 from last year’s $1.22 per share. VAR’s profit will be $85.57 million for 27.20 P/E if the $0.94 EPS becomes a reality. After $0.89 actual earnings per share reported by Varian Medical Systems, Inc. for the previous quarter, Wall Street now forecasts 5.62% EPS growth.

Since January 5, 2017, it had 0 insider buys, and 11 selling transactions for $11.97 million activity. KUO JOHN W also sold $83,084 worth of Varian Medical Systems, Inc. (NYSE:VAR) shares. The insider KENNEDY KOLLEEN T sold 56,573 shares worth $5.64M. WILSON DOW R sold $1.18 million worth of stock or 13,334 shares. The insider LARET MARK R sold 11,302 shares worth $944,408. The insider BOSTROM SUSAN L sold $326,902.

Alecta Pensionsforsakring Omsesidigt increased Alphabet Inc stake by 7,000 shares to 1.69M valued at $1.34 billion in 2016Q4. It also upped Graco Inc (NYSE:GGG) stake by 82,800 shares and now owns 1.23M shares. Mead Johnson (NYSE:MJN) was raised too.

Among 10 analysts covering Varian Medical Systems Inc. (NYSE:VAR), 4 have Buy rating, 1 Sell and 5 Hold. Therefore 40% are positive. Varian Medical Systems Inc. had 18 analyst reports since August 27, 2015 according to SRatingsIntel. The rating was maintained by Barrington Research on Friday, January 27 with “Outperform”. The firm has “Neutral” rating given on Thursday, November 12 by Citigroup. RBC Capital Markets maintained the shares of VAR in report on Monday, January 23 with “Sector Perform” rating. The firm has “Outperform” rating by Barrington Research given on Tuesday, January 12. As per Thursday, April 27, the company rating was maintained by RBC Capital Markets. Brean Capital maintained Varian Medical Systems, Inc. (NYSE:VAR) on Thursday, April 28 with “Buy” rating. RBC Capital Markets initiated it with “Sector Perform” rating and $86 target in Tuesday, December 22 report. The stock of Varian Medical Systems, Inc. (NYSE:VAR) earned “Neutral” rating by Robert W. Baird on Wednesday, September 28. The firm has “Sell” rating by Goldman Sachs given on Monday, September 28. The company was upgraded on Monday, May 8 by Citigroup.

Investors sentiment increased to 0.9 in 2016 Q4. Its up 0.01, from 0.89 in 2016Q3. It increased, as 38 investors sold VAR shares while 188 reduced holdings. 59 funds opened positions while 144 raised stakes. 88.84 million shares or 2.22% less from 90.86 million shares in 2016Q3 were reported. Papp L Roy has invested 0.69% in Varian Medical Systems, Inc. (NYSE:VAR). Da Davidson & has invested 0.01% in Varian Medical Systems, Inc. (NYSE:VAR). Nuance Limited Liability accumulated 0.42% or 55,781 shares. Alliancebernstein Lp stated it has 175,201 shares or 0.01% of all its holdings. Greenleaf Tru invested 0.01% of its portfolio in Varian Medical Systems, Inc. (NYSE:VAR). Cibc Corp reported 0.01% stake. Apg Asset Management Nv holds 0.14% of its portfolio in Varian Medical Systems, Inc. (NYSE:VAR) for 898,760 shares. First Eagle Mngmt Ltd Liability invested in 4.32 million shares. Ibm Retirement Fund reported 7,578 shares. King Luther Corporation reported 0% in Varian Medical Systems, Inc. (NYSE:VAR). Next Financial Gp Incorporated Inc stated it has 0% in Varian Medical Systems, Inc. (NYSE:VAR). Gam Holdings Ag reported 0.08% stake. Mutual Of America Cap Ltd Limited Liability Company has 10,112 shares for 0.02% of their portfolio. Shell Asset Com owns 32,815 shares. Baillie Gifford And Communication stated it has 0.01% in Varian Medical Systems, Inc. (NYSE:VAR).

The stock increased 0.74% or $0.1 on June 9, reaching $13.7. About shares traded. GasLog Ltd (NYSE:GLOG) has risen 20.14% since June 12, 2016 and is uptrending. It has outperformed by 3.44% the S&P500.